SPEAR-bladder (study informing treatment pathway decision in bladder cancer): First-through third-line time to treatment failure in the US

被引：3

作者：

Doshi, Gurjyot K.

Bhanegaonkar, Abhijeet

Bharmal, Murtuza

Phatak, Hemant

Boyd, Marley

Aguilar, Kathleen M.

Kearney, Mairead

机构：

[1] McKesson Specialty Hth, US Oncol Network, Houston, TX USA

[2] EMD Serono Inc, Rockland, MA USA

[3] Merck KGaA, Darmstadt, Germany

来源：

关键词：

D O I：

10.1200/JCO.2018.36.15_suppl.4544

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

4544

引用

页数：2